Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00526435 · ClinicalTrials.gov registry record · Phase 3
Evaluation of Walk With Ease in Arthritis
A Phase 3 study of Arthritis, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 3
- Development phase
- 468
- Enrollment target
- 1
- Study location
NCT00526435 is a Phase 3 study of Arthritis that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 468 participants, below the 4,500-participant average among 48 other Arthritis trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00526435, a Phase 3 study of Arthritis, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 468 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to determine the whether the Walk with Ease (WWE) program in its 2 version (group-assisted and self-directed) can increase physical activity and fitness levels among individuals (18 years and older) with arthritis over the long-term. Participants will be approximately 657 subjects from 20-24 rural and urban communities across North Carolina. It is expected that participants in the WWE program will have reduced pain, improved function and increased activity levels after participation in this 6-week program.
Conditions Studied
Interventions
- BEHAVIORAL Walk with Ease - Group
- BEHAVIORAL Walk with Ease - Self
Study Locations (1)
North Carolina
- University of North Carolina - Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 468 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00526435
The ClinicalTrials.gov registry entry for NCT00526435 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 468 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,500-participant average among 48 other Arthritis trials with a reported enrollment target (90% lower). The listed sponsor is Centers for Disease Control and Prevention, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Walk with Ease - Group is the first listed.
NCT00526435 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00526435 about?
NCT00526435 is a clinical study titled "Evaluation of Walk With Ease in Arthritis". The overall goal of this study is to determine the whether the Walk with Ease (WWE) program in its 2 version (group-assisted and self-directed) can increase physical activity and fitness levels among individuals (18 years and older) with arthritis over the long-term. Participants will be approximate...
What is the current status of trial NCT00526435?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 468 participants. The study started on 2007-10. Estimated completion is 2010-01.
What conditions does trial NCT00526435 study?
This clinical trial studies the following conditions: Arthritis.
What interventions are being tested in trial NCT00526435?
The interventions under investigation include: Walk with Ease - Group (BEHAVIORAL), Walk with Ease - Self (BEHAVIORAL).
Who is sponsoring clinical trial NCT00526435?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00526435 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
COMPLETED · Phase 3
-
A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy
RECRUITING
-
Expanding Exercise Programming for Veterans Through Telehealth
RECRUITING · NA
-
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
RECRUITING
-
Evaluation of the Walk With Ease Program for Fall Prevention
RECRUITING · Phase 1
-
Ultralow Dose PET Imaging for 18F-NaF Uptake
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.